fig3
Figure 3. Proposed study design to evaluate biomarkers. (A) biomarkers to assess patient prognosis; (B) biomarkers to assess response to treatment.
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Navigation
Committee on Publication Ethics
https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
